In nonalcoholic fatty liver disease, allyl isothiocyanate (AITC) ameliorates lipid accumulation and inflammation through the SIRT1/AMPK and NF-κB signaling pathways (69). This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.